Dapivirine: all 30 studies that test it
Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.
- Long-Acting HIV Pre-Exposure Prophylaxis Integrated With Sexual and Reproductive Health - cRCTRecruitingNCT06250504Phase 3
- Randomized, Open Label Safety Trial of Dapivirine Vaginal Ring and Oral TRUVADA® Use in PregnancyCompletedNCT03965923Phase 3Results posted
- Safety and Pharmacokinetic Study of Dapivirine Gel (0.05%) Administered Rectally to HIV-1 Seronegative AdultsCompletedNCT03239483Phase 1Results posted
- To Assess Continued Safety of and Adherence to the Dapivirine (25 mg) Vaginal Ring-004 in Healthy, HIV-negative WomenCompletedNCT02862171Phase 3Results posted
- Trial to Assess the Continued Safety of and Adherence to a Vaginal Ring Containing Dapivirine in WomenCompletedNCT02858037Phase 3Results posted
- Safety and Pharmacokinetics of Dapivirine Vaginal Ring in Post-menopausal WomenCompletedNCT02010593Phase 2Results posted
- Phase 3 Safety and Effectiveness Trial of Dapivirine Vaginal Ring for Prevention of HIV-1 in WomenCompletedNCT01617096Phase 3Results posted
- Relative Bioavailability Trial of Dapivirine Ring-004 and Ring-008CompletedNCT05416021Phase 1
- Pharmacokinetic Study of Dapivirine Gel Administered Rectally to HIV-1 Seronegative AdultsCompletedNCT03393468Phase 1
- Reversing the Epidemic in Africa With Choices in HIV Prevention (REACH)WithdrawnNCT03074786Phase 2
- Dapivirine Gel Rectal Safety and PK StudyWithdrawnNCT03044379Phase 1
- Safety and Pharmacokinetic Trial in Healthy HIV-Negative Women to Assess the Delivery of Dapivirine From a Vaginal RingCompletedNCT02920827Phase 1
- PK and Safety Study of Vaginal Rings Containing Dapivirine and LevonorgestrelCompletedNCT02855346Phase 1
- Pharmacokinetic Study of the Dapivirine Vaginal Ring in Lactating WomenCompletedNCT02808949Phase 1
- PK/PD of Single Dose Dapivirine Vaginal FilmCompletedNCT01924091Phase 1
- DDI Potential: Dapivirine Vaginal Ring and Miconazole NitrateCompletedNCT01731574Phase 1
- Assessing the Safety of Dapivirine Gel and Film FormulationsCompletedNCT01548560Phase 1
- A Safety and Efficacy Trial of Dapivirine Vaginal Ring in AfricaWithdrawnNCT01337583Phase 3
- A Safety and Efficacy Trial of Dapivirine Vaginal Ring in AfricaWithdrawnNCT01337570Phase 3
- Male Tolerance Study of Dapivirine Gel Following Multiple Topical Penile ExposuresCompletedNCT01277640Phase 1
- A Safety and Pharmacokinetic Study for Dapivirine and Maraviroc Gel in BelgiumWithdrawnNCT01242579Phase 1
- A Safety Study to Assess the Delivery of Dapivirine From a Matrix Vaginal RingCompletedNCT01144676Phase 1
- An Expanded Safety Study of Dapivirine Gel 4789 in AfricaCompletedNCT00917904Phase 1/2
- An Expanded Safety Study of Dapivirine Gel 4759 in AfricaCompletedNCT00917891Phase 1/2
- Feasibility Study of a Vaginal Ring for Delivery of TMC120 (Dapivirine)CompletedNCT00700284Phase 1
- Safety and Feasibility Study of Dapivirine (TMC120) Vaginal Ring in BelgiumCompletedNCT00332995Phase 1
- A Safety Study of Dapivirine (TMC120) Vaginal Microbicide Gel in BelgiumCompletedNCT00309205Phase 1/2
- A Safety Study of Dapivirine (TMC120) Vaginal Microbicide Gel in South AfricaWithdrawnNCT00304668Phase 1/2
- A Study to Assess the Pharmacokinetics of Dapivirine (TMC120) Vaginal Microbicide GelCompletedNCT00304642Phase 1
- A Safety and Tolerability Study of Dapivirine (TMC120) Vaginal Microbicide GelCompletedNCT00303576Phase 1/2